Privium Fund Management B.V. Zai Lab LTD Transaction History
Privium Fund Management B.V.
- $469 Million
- Q2 2025
A detailed history of Privium Fund Management B.V. transactions in Zai Lab LTD stock. As of the latest transaction made, Privium Fund Management B.V. holds 132,189 shares of ZLAB stock, worth $4.47 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
132,189
Previous 132,189
-0.0%
Holding current value
$4.47 Million
Previous $4.78 Million
3.24%
% of portfolio
0.98%
Previous 1.25%
Shares
8 transactions
Others Institutions Holding ZLAB
# of Institutions
170Shares Held
38.6MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$204 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$187 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$136 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$74.4 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$53.7 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.31B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...